IL186710A - Influenza A virus is isolated from dogs, a drug and vaccine that include it and its use - Google Patents

Influenza A virus is isolated from dogs, a drug and vaccine that include it and its use

Info

Publication number
IL186710A
IL186710A IL186710A IL18671007A IL186710A IL 186710 A IL186710 A IL 186710A IL 186710 A IL186710 A IL 186710A IL 18671007 A IL18671007 A IL 18671007A IL 186710 A IL186710 A IL 186710A
Authority
IL
Israel
Prior art keywords
vaccine
virus
compositions
same
canine influenza
Prior art date
Application number
IL186710A
Other languages
English (en)
Hebrew (he)
Other versions
IL186710A0 (en
Original Assignee
Cornell Res Foundation Inc
The Government Of The Us Secretary Of The Department Of Health And Human Services Centers For Diseas
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc, The Government Of The Us Secretary Of The Department Of Health And Human Services Centers For Diseas, Univ Florida filed Critical Cornell Res Foundation Inc
Publication of IL186710A0 publication Critical patent/IL186710A0/en
Publication of IL186710A publication Critical patent/IL186710A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL186710A 2005-04-21 2007-10-17 Influenza A virus is isolated from dogs, a drug and vaccine that include it and its use IL186710A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67344305P 2005-04-21 2005-04-21
PCT/US2006/015090 WO2006116082A1 (en) 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines

Publications (2)

Publication Number Publication Date
IL186710A0 IL186710A0 (en) 2008-02-09
IL186710A true IL186710A (en) 2017-09-28

Family

ID=37215064

Family Applications (3)

Application Number Title Priority Date Filing Date
IL186710A IL186710A (en) 2005-04-21 2007-10-17 Influenza A virus is isolated from dogs, a drug and vaccine that include it and its use
IL208707A IL208707B (en) 2005-04-21 2010-10-14 Materials and methods for controlling respiratory diseases in dogs
IL249236A IL249236B (en) 2005-04-21 2016-11-27 Materials and methods for controlling respiratory diseases in dogs

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL208707A IL208707B (en) 2005-04-21 2010-10-14 Materials and methods for controlling respiratory diseases in dogs
IL249236A IL249236B (en) 2005-04-21 2016-11-27 Materials and methods for controlling respiratory diseases in dogs

Country Status (16)

Country Link
EP (3) EP1871885B8 (enExample)
JP (6) JP2008536526A (enExample)
KR (3) KR101738937B1 (enExample)
CN (3) CN101253267A (enExample)
AU (1) AU2006240038B2 (enExample)
BR (2) BR122018012345B1 (enExample)
CA (1) CA2606429A1 (enExample)
ES (1) ES2570758T3 (enExample)
IL (3) IL186710A (enExample)
MX (3) MX339202B (enExample)
NO (2) NO345667B1 (enExample)
NZ (2) NZ583564A (enExample)
RU (2) RU2449014C2 (enExample)
SG (2) SG10201910006WA (enExample)
WO (1) WO2006116082A1 (enExample)
ZA (1) ZA200708897B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CN101253267A (zh) * 2005-04-21 2008-08-27 佛罗里达大学研究基金公司 用于犬科动物中呼吸系统疾病控制的物质和方法
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US8124335B2 (en) 2005-05-06 2012-02-28 Gen-Probe Incorporated Compositions and assays to detect influenza virus A and B nucleic acids
US7425336B2 (en) * 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
NZ566490A (en) * 2005-10-07 2011-06-30 Pfizer Prod Inc Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
AU2013205112C1 (en) * 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
AU2006304747B2 (en) * 2005-10-19 2013-10-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
GB0613977D0 (en) 2006-02-07 2006-08-23 Peptcell Ltd Peptide sequences and compositions
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
WO2008070332A2 (en) * 2006-10-25 2008-06-12 Intervet International B.V. Feline influenza vaccine and method of use
CN101838708B (zh) * 2010-03-30 2012-07-18 华南农业大学 一种检测犬流感的方法
EP2953967B1 (en) * 2013-02-07 2019-05-01 Massachusetts Institute of Technology Human adaptation of h5 influenza
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
WO2017004453A1 (en) * 2015-07-02 2017-01-05 Indevr, Inc. Universal priming mixture for amplification of influenza viral gene segments for diagnostic applications
EP3980445A1 (en) * 2019-06-07 2022-04-13 Intervet International B.V. Mdbk irf3/irf7 knock out mutant cell and its use for vaccine production
CN110592276A (zh) * 2019-07-08 2019-12-20 北京世纪元亨动物防疫技术有限公司 用于检测犬流感病毒的特异性引物及试剂盒
CN115074461B (zh) * 2021-03-11 2023-08-25 上海市农业科学院 犬流感病毒、犬冠状病毒和犬呼肠孤病毒的三重pcr检测方法
CN115725517B (zh) * 2022-09-01 2026-01-02 军事科学院军事医学研究院军事兽医研究所 一种h3n2犬流感重组病毒株及其应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5106739A (en) 1989-04-18 1992-04-21 Calgene, Inc. CaMv 355 enhanced mannopine synthase promoter and method for using same
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5612487A (en) 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
UA48104C2 (uk) 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
RU2193065C2 (ru) * 1994-03-14 2002-11-20 Мерк энд Ко. Инк. Конструкция днк (варианты), днк-вектор, иммуногенная композиция против вируса гриппа, способ индукции иммунного ответа, вакцина и способ вакцинации
JP3745370B2 (ja) * 1994-03-30 2006-02-15 ヴァイロジェネティクス コーポレイション イヌヘルペスウイルスｇＢ、ｇＣおよびｇＤの、核酸およびアミノ酸配列とその利用
GB9524395D0 (en) 1995-11-29 1996-01-31 Nickerson Biocem Ltd Promoters
US6252139B1 (en) 1996-07-18 2001-06-26 The Salk Institute For Biological Studies Method of increasing growth and yield in plants
US6063385A (en) 1997-11-07 2000-05-16 Wisconsin Alumni Research Foundation DNA vaccine for parvovirus
US6472375B1 (en) 1998-04-16 2002-10-29 John Wayne Cancer Institute DNA vaccine and methods for its use
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6579528B1 (en) * 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6482414B1 (en) * 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
EP1133556B1 (en) 1998-11-24 2006-02-08 Pioneer Hi-Bred International, Inc. Root-preferred promoters and their use
JP2000230931A (ja) * 1998-12-07 2000-08-22 Katakura Industries Co Ltd 家畜インフルエンザウイルスに対する抗体の検出方法およびこれに用いるキット
DE19960843A1 (de) 1999-12-16 2001-06-28 Florian Grundler Wurzelspezifischer Promotor
HU229101B1 (en) * 2000-04-28 2013-07-29 St Jude Childrens Res Hospital Dna transfection system for the generation of infectious influenza virus
BR0111819A (pt) * 2000-06-23 2004-01-06 American Cyanamid Co Moléculas de ácido nucléico isoladas, e, seq ência de aminoácido isolada
US6455760B1 (en) 2000-11-16 2002-09-24 The Salk Institute Of Biological Studies Expression of flavin-containing monoxygenases in plants
US20040067506A1 (en) 2000-12-04 2004-04-08 Ben Scheres Novel root specific promoter driving the expression of a novel lrr receptor-like kinase
EP1494708A1 (en) * 2002-04-12 2005-01-12 Capua, Ilaria Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
US7285656B2 (en) 2002-04-26 2007-10-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Natural Resources Canada, Canadian Forest Service Root-specific conifer gene promoter and its use
WO2004029213A2 (en) * 2002-09-28 2004-04-08 Massachusetts Institute Of Technology Compositions and methods for delivery of short interfering rna and short hairpin rna
WO2004057021A2 (en) * 2002-12-19 2004-07-08 UNIVERSITé LAVAL Molecular methods and compositions for detecting and quantifying respiratory viruses
US20040123349A1 (en) 2002-12-20 2004-06-24 Qi Xie SINAT5, an Arabidopsis thaliana gene promotes ubiquitin related degradation
CA2523676A1 (en) * 2003-05-15 2005-02-17 The Board Of Regents For Oklahoma State University Dna vaccine expressing ha1 of equine-2 influenza virus
CN1458168A (zh) * 2003-06-02 2003-11-26 中国农业科学院哈尔滨兽医研究所 重组猪流感病毒np抗原、其制备方法及在诊断中的应用
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
CN101253267A (zh) * 2005-04-21 2008-08-27 佛罗里达大学研究基金公司 用于犬科动物中呼吸系统疾病控制的物质和方法
NZ566490A (en) * 2005-10-07 2011-06-30 Pfizer Prod Inc Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
AU2006304747B2 (en) * 2005-10-19 2013-10-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus

Also Published As

Publication number Publication date
NZ562661A (en) 2010-04-30
ES2570758T3 (es) 2016-05-20
KR101738940B1 (ko) 2017-06-08
JP2020031658A (ja) 2020-03-05
MX2018010571A (es) 2022-01-25
AU2006240038B2 (en) 2012-07-05
RU2007143041A (ru) 2009-05-27
SG10201406043TA (en) 2014-11-27
EP2495326B1 (en) 2019-11-20
JP6663416B2 (ja) 2020-03-11
HK1111729A1 (zh) 2008-08-15
EP2489739A3 (en) 2013-08-28
JP2018050636A (ja) 2018-04-05
BR122018012345B1 (pt) 2021-10-26
NZ583564A (en) 2011-09-30
AU2006240038A1 (en) 2006-11-02
NO20180601A1 (no) 2008-01-21
EP2495326A3 (en) 2013-08-28
RU2020100038A (ru) 2021-07-09
IL208707B (en) 2020-01-30
MX358750B (es) 2018-08-31
KR101474011B1 (ko) 2014-12-23
EP1871885A4 (en) 2009-09-16
IL208707A0 (en) 2010-12-30
JP2008536526A (ja) 2008-09-11
KR20080039836A (ko) 2008-05-07
CN103451158B (zh) 2018-11-23
IL249236B (en) 2021-07-29
RU2011153597A (ru) 2013-07-10
CN107099512A (zh) 2017-08-29
ZA200708897B (en) 2009-01-28
KR101738937B1 (ko) 2017-05-23
EP2489739A2 (en) 2012-08-22
BRPI0610503A2 (pt) 2010-06-29
EP2489739B1 (en) 2019-11-20
BRPI0610503B1 (pt) 2022-05-31
KR20150082628A (ko) 2015-07-15
EP1871885A1 (en) 2008-01-02
JP2013031440A (ja) 2013-02-14
JP6042131B2 (ja) 2016-12-14
KR20140091770A (ko) 2014-07-22
EP1871885B1 (en) 2016-02-17
JP6301855B2 (ja) 2018-03-28
JP2015144604A (ja) 2015-08-13
NO345667B1 (no) 2021-06-07
WO2006116082A1 (en) 2006-11-02
RU2711791C2 (ru) 2020-01-22
EP2495326A2 (en) 2012-09-05
MX339202B (es) 2016-05-13
SG10201910006WA (en) 2019-11-28
JP2024043541A (ja) 2024-03-29
CA2606429A1 (en) 2006-11-02
NO342494B1 (no) 2018-06-04
IL249236A0 (en) 2017-01-31
EP1871885B8 (en) 2017-08-02
IL186710A0 (en) 2008-02-09
CN103451158A (zh) 2013-12-18
CN101253267A (zh) 2008-08-27
RU2449014C2 (ru) 2012-04-27
NO20075961L (no) 2008-01-21

Similar Documents

Publication Publication Date Title
IL186710A (en) Influenza A virus is isolated from dogs, a drug and vaccine that include it and its use
AP2008004625A0 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
ZA200800505B (en) Modified influenza virus for monitoring and improving vaccine efficiency
IL186611A0 (en) Vaccine against pandemic strains of influenza viruses
SG2014012868A (en) Functional influenza virus like particles (vlps)
IL183888A0 (en) Rescue of influenza virus
IL189329A0 (en) Vaccination against dengue virus infection
EP2091960A4 (en) PEPTIDE VACCINE AGAINST INFLUENZA VIRUS
IL226253A0 (en) Canine/Miami/05 influenza virus capable of infecting canine animals and methods using it
IL196024A0 (en) Influenza vaccine
ZA200802892B (en) Vaccines and methods to treat canine influenza
NO20054608D0 (no) Influensavirusvaksine
PT2121011E (pt) Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
EP2170382A4 (en) ATTENUATED INFLUENZA VIRUS AND LIVE VACCINE CONTAINING IT
ZA200809056B (en) Influenza virus vaccine
EP1948227A4 (en) COMBINATORY ANTIGEN VACCINE AGAINST FLU
EP1906998A4 (en) GRAPE VACCINE FORMULATION ON PEPTIDE BASE
PL1942933T3 (pl) Szczepionki przeciw grypie psów
PL2422810T3 (pl) Szczepionka przeciw grypie
ATE491468T1 (de) Hunde-influenza-virus und relevante zusammensetzungen und anwendungsverfahren
ZA200701674B (en) Vaccine composition against Hepatitis C virus
SI1951299T1 (sl) Cepiva proti influenci, ki vkljuäśujejo kombinacije adjuvantov iz delcev in imunopotenciatorjev
EP2097103A4 (en) VACCINE FORMULATIONS AGAINST INFLUENZA
EP1871786A4 (en) PEPTIDE VACCINE AGAINST THE GRIPPEVIRUS
IL177903A (en) Vaccine for Infectious Stock Disease Virus and its Use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed